Prosecution Insights
Last updated: April 19, 2026
Application No. 18/324,648

PHOTOCURABLE BLACK SILICONE COMPOSITION AND CURED PRODUCT THEREOF

Non-Final OA §103
Filed
May 26, 2023
Examiner
WHITELEY, JESSICA
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Dupont Toray Specialty Materials Kabushiki Kaisha
OA Round
1 (Non-Final)
88%
Grant Probability
Favorable
1-2
OA Rounds
2y 1m
To Grant
96%
With Interview

Examiner Intelligence

Grants 88% — above average
88%
Career Allow Rate
1317 granted / 1489 resolved
+23.4% vs TC avg
Moderate +7% lift
Without
With
+7.1%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
47 currently pending
Career history
1536
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
31.5%
-8.5% vs TC avg
§102
34.8%
-5.2% vs TC avg
§112
16.6%
-23.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1489 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim s 1-11 are rejected under 35 U.S.C. 103 as being unpatentable over Ogawa (WO 2021167051) in view of Kuse et al (US 2017/0232775) . With regards to claim s 1 - 2 and 6 7 , Ogawa teaches a photocurable silicone composition (title and abstract) that contains an organopolysiloxane having at least two alkenyl groups, a compound having at least two mercapto groups per molecule, and a photoinitiator (0009). Ogawa further teaches the photoinitiator to include compounds that are α-hydroxyketone or phosphine oxide photoinitiators (0043). Ogawa does not teach the addition of black pigments. Kuse teaches a curable composition that contains a crosslinker that is a multifunctional mercapto compound (0057), a vinyl group containing organopolysiloxane (0073) and a black pigment that includes carbon black and perylene pigments (0065-0066). Kuse teaches the motivation for adding these pigments to be because is converts light energy to heat (0065) which facilitates curing where the light cannot reach. Ogawa and Kuse are analogous in the art of orgaonpolysiloxane compositions. In light of the benefit above, it would have been obvious to one skilled in the art prior to the effective filing date of the present invention to add the black pigments of Kuse to the composition of Ogawa, thereby obtaining the present invention. With regards to claim 3 , Ogawa and Kuse do not teach the particle size of the pigments added to the composition. However, w here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the particle size of the pigments in order to achieve the desired optical properties such as gloss, intensity, opacity, and rheology of the composition. With regards to claim 4 , Ogawa and Kuse do not teach the specific surface area of the pigments added to the composition. However, w here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the surface area of the pigments in order to achieve the desired properties such as color and hiding power, dispersion and rheology, durability and weathering, and mechanical properties of the composition. With regards to claim 5 , Ogawa and Kuse do not teach the oil absorption of the pigments added to the composition. However, w here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). The oil absorption of pigments is the amount of oil needed to form a stiff, spreadable paste with a specific weight of pigment. In this case, one skilled in the art prior to the effective filing date of the present invention would know to select a pigment having the desired oil absorption in order to balance the amount of oil needed to form said paste with the desired color and intensity of color . With regards to claim 8 , Ogawa teaches the composition to contain 10 to 99 parts of the organopolysiloxane having at least two alkenyl groups (0023). With regards to claim 9 , Ogawa teaches the amount of the mercapto compound to be 13.57% (example 1). With regards to claim 10 , Ogawa teaches the amount of the mercapto groups to be 0.2 to 3 moles per pole of alkenyl groups (0042). With regards to claim 11 , Ogawa teaches the use of the composition as a sealant (0053). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The following references teach the composition as claimed in claim 1 but do not include the black pigment: Takeuchi et al (US 2021/0269642), Chae et al (US 2022/0403115), Yook et al (US 2023/0013987), Chae et al (US 2023/0174722), and Liu et al (US 2022/0145020). Any inquiry concerning this communication or earlier communications from the examiner should be directed to FILLIN "Examiner name" \* MERGEFORMAT JESSICA WHITELEY whose telephone number is FILLIN "Phone number" \* MERGEFORMAT (571)272-5203 . The examiner can normally be reached FILLIN "Work Schedule?" \* MERGEFORMAT 8 - 5:00 . Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, FILLIN "SPE Name?" \* MERGEFORMAT Joseph Del Sole can be reached at FILLIN "SPE Phone?" \* MERGEFORMAT 5712721130 . The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-100 0. /JESSICA WHITELEY/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

May 26, 2023
Application Filed
Dec 12, 2025
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600808
CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELS
2y 5m to grant Granted Apr 14, 2026
Patent 12600888
DUAL-CURABLE ADHESIVE COMPOSITION
2y 5m to grant Granted Apr 14, 2026
Patent 12590264
PROFRAGRANCE CONJUGATES
2y 5m to grant Granted Mar 31, 2026
Patent 12590265
1-NORBORNAN-2-YLPROPAN-2-ONE AS A FRAGRANCE
2y 5m to grant Granted Mar 31, 2026
Patent 12583833
Enrichment of a Diastereomer in Magnolan
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
88%
Grant Probability
96%
With Interview (+7.1%)
2y 1m
Median Time to Grant
Low
PTA Risk
Based on 1489 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month